These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 34858023

  • 1. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.
    Choi JH, Jeong KB, Park YH, Yu I, Lee SJ, Lee MK, Kim SH, Lee WY, Yong SJ, Lee JH.
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3229-3237. PubMed ID: 34858023
    [Abstract] [Full Text] [Related]

  • 2. Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study.
    Lee JH, Park YH, Kang DR, Lee SJ, Lee MK, Kim SH, Yong SJ, Lee WY.
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3397-3406. PubMed ID: 33402820
    [Abstract] [Full Text] [Related]

  • 3. Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.
    Lodise TP, Li J, Gandhi HN, O'Brien G, Sethi S.
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2889-2900. PubMed ID: 33204085
    [Abstract] [Full Text] [Related]

  • 4. Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study.
    Yu I, Park S, Hong SH, Chang MS, Lee SJ, Yong SJ, Lee WY, Kim SH, Lee JH.
    J Pers Med; 2022 Jul 21; 12(7):. PubMed ID: 35887686
    [Abstract] [Full Text] [Related]

  • 5. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
    Wang CY, Lai CC, Yang WC, Lin CC, Chen L, Wang HC, Yu CJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Jul 21; 11():2775-2783. PubMed ID: 27877031
    [Abstract] [Full Text] [Related]

  • 6. Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
    Janson C, Stratelis G, Miller-Larsson A, Harrison TW, Larsson K.
    Int J Chron Obstruct Pulmon Dis; 2017 Jul 21; 12():3055-3064. PubMed ID: 29089754
    [Abstract] [Full Text] [Related]

  • 7. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
    Tashkin DP, Miravitlles M, Celli BR, Metzdorf N, Mueller A, Halpin DMG, Anzueto A.
    Respir Res; 2018 Oct 05; 19(1):196. PubMed ID: 30290801
    [Abstract] [Full Text] [Related]

  • 8. Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
    O'Byrne PM, Pedersen S, Carlsson LG, Radner F, Thorén A, Peterson S, Ernst P, Suissa S.
    Am J Respir Crit Care Med; 2011 Mar 01; 183(5):589-95. PubMed ID: 20889908
    [Abstract] [Full Text] [Related]

  • 9. Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD.
    Chang TY, Chien JY, Wu CH, Dong YH, Lin FJ.
    Chest; 2020 May 01; 157(5):1117-1129. PubMed ID: 31887282
    [Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M, Du Y, Chen H, Jiang D, Xu Z.
    Int Immunopharmacol; 2019 Dec 01; 77():105950. PubMed ID: 31629940
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.
    Yawn BP, Li Y, Tian H, Zhang J, Arcona S, Kahler KH.
    Int J Chron Obstruct Pulmon Dis; 2013 Dec 01; 8():295-304. PubMed ID: 23836970
    [Abstract] [Full Text] [Related]

  • 12. Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety.
    Suissa S, Dell'Aniello S, Ernst P.
    COPD; 2022 Dec 01; 19(1):109-117. PubMed ID: 35385359
    [Abstract] [Full Text] [Related]

  • 13. Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study.
    Qian CJ, Coulombe J, Suissa S, Ernst P.
    Br J Clin Pharmacol; 2017 Sep 01; 83(9):2077-2086. PubMed ID: 28425216
    [Abstract] [Full Text] [Related]

  • 14. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC.
    Respir Med; 2017 Sep 01; 130():75-84. PubMed ID: 29206637
    [Abstract] [Full Text] [Related]

  • 15. Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.
    Kern DM, Davis J, Williams SA, Tunceli O, Wu B, Hollis S, Strange C, Trudo F.
    Respir Res; 2015 Apr 23; 16(1):52. PubMed ID: 25899176
    [Abstract] [Full Text] [Related]

  • 16. Inhaled Corticosteroids Use and Risk of Invasive Pneumococcal Disease in a Population-based Study.
    Torén K, Blanc PD, Qvarfordt I, Aspevall O, Schiöler L.
    Ann Am Thorac Soc; 2020 Dec 23; 17(12):1570-1575. PubMed ID: 32649216
    [Abstract] [Full Text] [Related]

  • 17. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P.
    Clin Drug Investig; 2010 Dec 23; 30(9):565-79. PubMed ID: 20593912
    [Abstract] [Full Text] [Related]

  • 18. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.
    Dalby C, Polanowski T, Larsson T, Borgström L, Edsbäcker S, Harrison TW.
    Respir Res; 2009 Oct 31; 10(1):104. PubMed ID: 19878590
    [Abstract] [Full Text] [Related]

  • 19. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.
    J Intern Med; 2013 Jun 31; 273(6):584-94. PubMed ID: 23495860
    [Abstract] [Full Text] [Related]

  • 20. Inhaled Corticosteroid-Related Tuberculosis in the Real World Among Patients with Asthma and COPD: A 10-Year Nationwide Population-Based Study.
    Lee CM, Heo J, Han SS, Moon KW, Lee SH, Kim YJ, Lee SJ, Kwon JW.
    J Allergy Clin Immunol Pract; 2019 Apr 31; 7(4):1197-1206.e3. PubMed ID: 30339858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.